BAKER BROS. ADVISORS LP
Total Volume
$410.3M
29 filings
Purchases
$73.1M
74 buy txns
Sales
$319.1M
10 sell txns
Net Activity
-$246.0M
net sold
Profile
- Filings
- 29
- Buy transactions
- 74
- Sell transactions
- 10
- Companies
- 17
- Active
- 2025–2026
BAKER BROS. ADVISORS LP has filed 29 reports across 17 companies, totaling $410.3M in disclosed volume. Sales ($319.1M) outpace purchases ($73.1M). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Celcuity Inc. (CELC)
3 filings
$327.3M
$9.6M bought
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
3 filings
$63.5M
$61.9M bought
INCYTE CORP (INCY)
4 filings
$6.3M
Kiniksa Pharmaceuticals International, plc (KNSA)
1 filing
$3.5M
Entrada Therapeutics, Inc. (TRDA)
2 filings
$1.6M
$1.6M bought
ACADIA PHARMACEUTICALS INC (ACAD)
1 filing
$1.4M
Kodiak Sciences Inc. (KOD)
1 filing
$1.4M
Kymera Therapeutics, Inc. (KYMR)
1 filing
$1.2M
KALA BIO, Inc. (KALA)
1 filing
$1.1M
Denali Therapeutics Inc. (DNLI)
2 filings
$778.8K
Replimune Group, Inc. (REPL)
1 filing
$677.3K
BICYCLE THERAPEUTICS PLC (BCYC)
1 filing
$538.1K
vTv Therapeutics Inc. (VTVT)
2 filings
$446.7K
Prelude Therapeutics Inc (PRLD)
2 filings
$299.7K
BeOne Medicines Ltd. (ONC)
2 filings
$262.0K
DBV Technologies S.A. (DBVT)
1 filing
$0
IGM Biosciences, Inc. (IGMS)
1 filing
$0
Trading History
| Jul 16 | CELC Celcuity Inc. | BAKER BROS. ADVISORS LP | Insider | Sell | $317.8M |
| Jul 2 | KOD Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Insider | Other | $0 |
| Jun 29 | VTVT vTv Therapeutics Inc. | BAKER BROS. ADVISORS LP | Insider | Other | $0 |
| Jun 25 | KYMR Kymera Therapeutics, Inc. | BAKER BROS. ADVISORS LP | Insider | Other | $0 |
| Jun 18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Insider | Grant | $0 |
| Jun 15 | ONC BeOne Medicines Ltd. | BAKER BROS. ADVISORS LP | Insider | Grant | $0 |
| Jun 10 | PRLD Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Insider | Other | $0 |
| Jun 10 | INCY INCYTE CORP | BAKER BROS. ADVISORS LP | Insider | Grant | $0 |
| Jun 5 | DNLI Denali Therapeutics Inc. | BAKER BROS. ADVISORS LP | Insider | Grant | $0 |
| Jun 2 | ACAD ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Insider | Grant | $0 |
| Jun 2 | KNSA Kiniksa Pharmaceuticals International, plc | BAKER BROS. ADVISORS LP | Insider | Grant | $0 |
| May 27 | ONC BeOne Medicines Ltd. | BAKER BROS. ADVISORS LP | Insider | Sell | $262.0K |
| May 11 | INCY INCYTE CORP | BAKER BROS. ADVISORS LP | Insider | Other | $0 |
| Apr 22 | PRLD Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Insider | Other | $0 |
| Apr 7 | REPL Replimune Group, Inc. | BAKER BROS. ADVISORS LP | Insider | Other | $0 |
| Apr 2 | INCY INCYTE CORP | BAKER BROS. ADVISORS LP | Insider | Grant | $0 |
| Jan 14 | DBVT DBV Technologies S.A. | BAKER BROS. ADVISORS LP | Insider | Other | $0 |
| Jan 6 | BCYC BICYCLE THERAPEUTICS PLC | BAKER BROS. ADVISORS LP | Insider | Grant | $0 |
| Dec 15 | DNLI Denali Therapeutics Inc. | BAKER BROS. ADVISORS LP | Insider | Other | $0 |
| Nov 24 | TRDA Entrada Therapeutics, Inc. | BAKER BROS. ADVISORS LP | Insider | Buy | $261.8K |
| Nov 12 | TRDA Entrada Therapeutics, Inc. | BAKER BROS. ADVISORS LP | Insider | Buy | $1.4M |
| Oct 2 | KALA KALA BIO, Inc. | BAKER BROS. ADVISORS LP | Insider | Sell | $1.1M |
| Oct 2 | INCY INCYTE CORP | BAKER BROS. ADVISORS LP | Insider | Grant | $0 |
| Sep 10 | CELC Celcuity Inc. | BAKER BROS. ADVISORS LP | Insider | Buy | $9.6M |
| Sep 5 | VTVT vTv Therapeutics Inc. | BAKER BROS. ADVISORS LP | Insider | Grant | $0 |
| Aug 20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Insider | Buy | $36.9M |
| Aug 20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Insider | Buy | $25.0M |
| Aug 18 | IGMS IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Insider | Other | $0 |
| Aug 1 | CELC Celcuity Inc. | BAKER BROS. ADVISORS LP | Insider | Other | $0 |
29 filings